Veru Reports Fiscal 2018 Second-Quarter Financial Results
-- Promising Oncology Drug Data to be Presented at Upcoming American Urological Association Medical Conference; FDA Waives Drug Application Fee; BE Clinical Studies Results Anticipated for Drugs in 2018; Clinical Trials for VERU-944 and VERU-111 Planned …